pimecrolimus
Viatris Ophthalmic Drug Fails Phase 3 for Blepharitis; Company Weighs Next Steps
Viatris; ophthalmic drug; Phase 3 study; blepharitis; MR-139; clinical trial failure; drug development; pimecrolimus; pipeline; strategic review
Actionable Insights Powered by AI
Viatris; ophthalmic drug; Phase 3 study; blepharitis; MR-139; clinical trial failure; drug development; pimecrolimus; pipeline; strategic review